Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• Platelet [3H]imipramine binding is a biomarker for serotonin transporter (SERT) density.
• Desipramine-defined binding is commonly used in population studies.
• Investigating alternative methods for SERT quantification is crucial for research.

Purpose of the Study:

• To compare sodium-dependent [3H]imipramine binding with desipramine-defined binding in human platelets.
• To evaluate the utility of sodium-dependent binding as a measure of SERT sites relevant to serotonin uptake.
• To explore potential age-dependent variations in binding parameters.

Main Methods:

• Quantification of sodium-dependent [3H]imipramine binding to intact human platelets.
• Comparison with binding assays using excess desipramine to define specific binding.
• Analysis of binding density (Bmax) and affinity (Kd) parameters.
• Assessment of correlations between different binding conditions and age-related effects.

Main Results:

• Sodium-dependent binding showed significantly lower density (Bmax) and higher affinity (Kd) compared to desipramine-defined binding.
• No significant correlation was observed between the two binding measures in individual subjects.
• No age-dependent variations were found in either binding assay.
• Results suggest distinct proportions of SERT sites are labeled under different assay conditions.

Conclusions:

• Sodium-dependent [3H]imipramine binding to intact platelets is a distinct measure from desipramine-defined binding.
• This method may be a valuable tool for estimating [3H]imipramine recognition sites relevant to serotonin uptake.
• It holds potential for use in studies involving patients with affective disorders.